Affordable Access

In vitro effects of verteporfin on ocular cells

Molecular Vision
Publication Date
  • Research Article
  • Biology
  • Medicine


Purpose Photodynamic therapy (PDT) laser light in conjunction with the benzoporphyrin derivative verteporfin is a current clinical treatment for choroidal vascular diseases such as age-related macular degeneration. The aim of this study was to examine the effects of PDT laser-activated and inactive verteporfin on various cultured ocular cells. Methods Primary human scleral fibroblasts (hFibro), primary human trabecular meshwork (TM) cells (hTMC), primary porcine TM cells (pTMC), and a human retinal pigment epithelial cell line (ARPE-19 cells) were treated with verteporfin with and without activation by PDT laser. Cell viability was determined according to mitochondrial enzyme activity (3-(4,5- dimethyl-2-thiazoyl)-2,5-diphenyl-2H-tetrazolium bromide assay). Results PDT laser treatment alone was insufficient to cause significant cell death in any of the cell types tested. Twenty-four-hour exposure to inactive verteporfin (without PDT laser) caused a dose-dependent decrease in cell viability in hFibro and hTMC, and to a lesser extent ARPE-19 cells. Verteporfin (0.5 µg/ml) without PDT laser activation caused a slight but statistically insignificant reduction in cell viability in hFibro (81.5%±19.3%), pTMC (82.9%±6.7%), hTMC (80.3%±7.7%), and ARPE-19 cells (84.5%±14.9%). Verteporfin (0.5 µg/ml) plus 50 µJ/cm2 PDT laser treatment significantly decreased viability in hFibro (13.5% ± 3.3%), pTMC (7.1%±1.5%), hTMC (11.1%±5.2%), and ARPE-19 (44.5%±7.8%). Similar results were obtained in cells where verteporfin incubation was followed by washout before PDT laser, indicating that verteporfin is internalized by the studied cell lines. Conclusions PDT laser-induced cell death was obtained with coincubation of verteporfin or preincubation followed by washout. These results suggest a potential future use of PDT therapy for selective in vivo removal of targeted ocular cells beyond the current use for destroying vascular endothelial cells.

There are no comments yet on this publication. Be the first to share your thoughts.